Dr. Jason Hsu leads a study that looks into the loss of follow-up visits with patients suffering from non-proliferative diabetic retinopathy. The study has found that a quarter of patients do not return within a year of receiving an anti-VEGF injection. Read more about the study from Healio.
Dr. Carl Regillo, Chief of Wills Eye Retina Service, explains the risk diabetes imposes on your vision if not treated or detected early. Watch the full clip here to learn more.
"I am so grateful for the staff at the Lansdale office. Eye injections are not the highlight of anyone's day. But - thanks to this group it makes it tolerable (not pleasant but not the worst thing). They are welcoming (even with the number of patients waiting in the wings), have a great sense of... read more